4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Torrent Pharmaceuticals Limited (TORNTPHARM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Ahmedabad, India with about 18,258 employees. Its market capitalization is roughly ₹1.84 trillion. In the fiscal year ended 2026-03-31, TORNTPHARM reported ₹137.5B in revenue and ₹21.6B in net income.
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹137.5B | ₹113.2B | ₹105.6B | ₹94.6B |
| Gross Profit | ₹102.3B | ₹84.3B | ₹77.7B | ₹66.4B |
| Operating Income (EBIT) | ₹34.4B | ₹29.3B | ₹25.7B | ₹21.4B |
| Net Income | ₹21.6B | ₹19.1B | ₹16.6B | ₹12.5B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹48.4B | ₹41.3B | ₹32.5B | ₹32.5B | ₹31.3B | — |
| Gross Profit | ₹36.7B | ₹31.1B | ₹24.5B | ₹24.5B | ₹23.5B | — |
| Operating Income (EBIT) | ₹10.7B | ₹8.5B | ₹8.8B | ₹8.8B | ₹8.3B | — |
| Net Income | ₹5.7B | ₹3.9B | ₹6.3B | ₹5.9B | ₹5.5B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹12.9B) | (₹10.8B) | (₹10.2B) | (₹8.6B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹443.1B | ₹149.9B | ₹150.6B | ₹150.1B | — |
| Total Liabilities | ₹267.3B | ₹74.0B | ₹82.0B | ₹88.1B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TORNTPHARM viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms